Bioxytran (OTCPK:BIXT) Conference December 11, 2025 02:55 PM ET Company ParticipantsMike Sheikh - Chief Communications OfficerMike SheikhAnna, you heard me good, right?ModeratorYes, perfect. All right.Mike SheikhPerfect.ModeratorOkay, welcome back, everyone. Next, we have Bioxytran. They are an OTCQB company trading under the ticker symbol BIXT. The company is a clinical stage biotech with three revolutionary platform technologies that were quickly developed using the power of AI. They have a broad-spectrum ...

VANCOUVER, British Columbia, Aug. 14, 2025 (GLOBE NEWSWIRE) -- via IBN -- Fifty1 AI Labs, Inc. (OTC: FITY), a leader in AI-powered drug repurposing and precision medicine, today announced the completion of the largest and most comprehensive study of Sickle Cell Disease (SCD) ever undertaken. Leveraging a decade's worth of real-world patient data, the study mapped disease progression and treatment outcomes at an unprecedented scale—marking a major milestone in the fight against this life-threatening genetic ...